Monalizumab, CAS [[1228763-95-8]]

Produktübersicht

• Artikelname: Monalizumab, CAS [[1228763-95-8]]
• Artikelnummer: TGM-T76691
• Hersteller Artikelnummer: T76691
• Alternativnummer: TGM-T76691-1MG,TGM-T76691-5MG,TGM-T76691-10MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

Monalizumab is a novel immune checkpoint inhibitor targeting natural killer cell population 2A (NKG2A). Monalizumab is a humanized monoclonal antibody against NKG2A that induces IFN-gamma production, thereby activating natural killer cell function. Monalizumab has antitumor activity and can be used to study neck squamous cell carcinoma (HNSCC).

Produkteigenschaften

• Reinheit: >95%
• CAS Nummer: [1228763-95-8]
• Target-Kategorie: Chk|||IFNAR